The FDA says it examined safety and immunogenicity data from a clinical study before authorizing the bivalent shots. In studying Pfizer’s new booster, 600 adults 55 and older received a single ...

The Food and Drug Administration authorized booster shots of the Pfizer-BioNTech coronavirus ... 1 in 4 of those fully vaccinated — have gotten the additional shots. The FDA expanded Pfizer’s ...

17, the FDA’s outside advisory committee is due to publicly review Pfizer’s data supporting ... to see more data before encouraging third booster shots for the general population starting ...

The new vaccines, developed by Moderna and Pfizer-BioNTech ... Preliminary data show that this booster will trigger the production of antibodies that recognize this form of SARS-CoV-2.

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

For everyone else, there's no new booster recommendation for now, though the FDA and CDC ... moving forward. Pfizer also said it will have a patient assistance program to keep shots free for ...

The findings reinforce advice recommending that those who received the J&J vaccine receive a second booster dose with an mRNA vaccine, the technology used in the Moderna and Pfizer shots ...

Here’s your go-to guide with everything you need to know about COVID-19, including testing expanding to more airports, ...

5) is already FDA-authorized under an EUA for ... based on clinical data from trials of BA.1 booster shots. Just beforehand, Moderna sued Pfizer/BioNTech for what it claims was patent infringement ...

US pharmaceutical company Pfizer has filed ... Drug Administration (FDA) this week for an emergency clearance to vaccinate children aged 5 to 11 with a 10-microgram booster dose against the ...

They occur most in women ages 30 to 49 -- about once for every 100,000 doses administered, the FDA said ... mixing vaccines for booster shots. Several countries, including Canada, already have ...